Drugs Targeting BRAF

Drugs Targeting BRAF2018-03-27T14:47:09+00:00

Drugs Targeting BRAF

TAFLINAR (dabrafenib) with MEKINIST (trametinib)

BRAF is another gene that can change in NSCLC. These two oral drugs are approved in combination for NSCLC with a change in BRAF called V600E. The drugs are approved only for cancer that has spread.

No announcement available or all announcement expired.